Jean-François Toussaint, Sanofi's global head of vaccines R&D, speaking at a conference at the company's site in Lyon last ...
The FDA announced Friday that it had approved the first at-home test for sexually transmitted infections, opening the pathway for more to come.
Sanofi SNY announced that the FDA has granted a fast-track designation to its mRNA vaccine candidate for the prevention of ...
The Food and Drug Administration (FDA) has cleared the Visby Medical Women’s Sexual Health Test for use at home to test for ...
In certain regions of Australia, chlamydia is rampant among koalas, with infection rates reaching alarming levels. For ...
The FDA has granted Visby Medical authorization to market their at-home, over-the-counter diagnostic test that detects ...
US FDA grants marketing authorization of first home test for Chlamydia, gonorrhoea and trichomoniasis: Silver Spring, Maryland Monday, March 31, 2025, 10:00 Hrs [IST] The US Food ...
For all treated chlamydia infections, 14.0% of patients received doxycycline—the CDC's recommended treatment—alone or with ...
Chlamydia vaccine candidate granted fast track designation by the US FDAChlamydia infection can contribute to pelvic inflammatory diseases in ...
Southwestern Sydney's koalas have avoided the chlamydia outbreak threatening the entire species. But their isolation has left them extremely inbred.
The FDA on Friday granted marketing authorization to the first at-home test for diagnosing chlamydia, gonorrhea, and trichomoniasis in females. The so-called Visby Medical Women's Sexual Health Test ...
Sanofi SNY announced that the FDA has granted a fast-track designation to its mRNA vaccine candidate for the prevention of chlamydia infection. The company plans to begin a phase I/II study soon ...